Germantown, TN, United States of America

Yichun Sun


Average Co-Inventor Count = 5.3

ph-index = 4

Forward Citations = 65(Granted Patents)


Location History:

  • Germantown, TN (US) (2005 - 2013)
  • North Potomac, MD (US) (2013 - 2014)

Company Filing History:


Years Active: 2005-2014

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Yichun Sun: Innovator in Tamper Prone Therapeutic Agents

Introduction

Yichun Sun is a notable inventor based in Germantown, TN (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of dosage forms that enhance the safety and efficacy of therapeutic agents. With a total of 6 patents to his name, his work is recognized for addressing critical issues in drug delivery systems.

Latest Patents

One of Yichun Sun's latest patents focuses on dosage forms for tamper prone therapeutic agents. This innovative dosage form is designed to reduce or retard the burst release of a drug contained within a tampered dosage form. The presence of a Tamper Prone Therapeutic Agent (TPTA) trap plays a crucial role in this mechanism. If the dosage form remains untampered, the TPTA trap does not significantly interfere with the drug's release rate. However, in cases of physical tampering, the TPTA trap effectively reduces or retards the burst release of the drug, enhancing patient safety.

Career Highlights

Throughout his career, Yichun Sun has worked with reputable organizations, including Atlantic Pharmaceuticals, Inc. and the University of Tennessee Research Foundation. His experience in these institutions has allowed him to collaborate with other professionals in the field and contribute to advancements in pharmaceutical technology.

Collaborations

Yichun Sun has collaborated with notable colleagues such as Atul J Shukla and James R Johnson. These partnerships have further enriched his research and development efforts in creating innovative therapeutic solutions.

Conclusion

Yichun Sun's contributions to the field of pharmaceuticals, particularly in the area of tamper prone therapeutic agents, highlight his commitment to enhancing drug safety and efficacy. His innovative approaches and collaborative efforts continue to make a significant impact in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…